Chronic Kidney Disease Stage 3 Clinical Trials

31 clinical trials for Chronic Kidney Disease Stage 3 across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Effects of Replacing High Protein Foods in People With Chronic Kidney Disease — RECRUITING · NA
• Berlin Longterm Observation of Vascular Events — RECRUITING
• A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) — RECRUITING · PHASE1
• Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes — RECRUITING · NA
• Urinary Tubular Biomarkers for Chronic Kidney Disease — RECRUITING
• Accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease: the eGFR-C study — ACTIVE_NOT_RECRUITING
• Prospective Decision Impact Trial of KidneyIntelX — ACTIVE_NOT_RECRUITING
• Prospective Decision Impact Clinical Utility Trial of KidneyIntelX — ACTIVE_NOT_RECRUITING
• A Cohort Study on the Integrated Management of Chronic Kidney Disease — NOT_YET_RECRUITING
• Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease — COMPLETED · PHASE2
• A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease. — COMPLETED · PHASE2
• Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis) — TERMINATED · PHASE2
• Controlling Hypertension Through Education and Coaching in Kidney Disease — COMPLETED · NA
• Reduction of the risk of dialysis — OTHER
• KPs Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in CKD Patients. — COMPLETED · NA
• Clinical Effectiveness of MyNutriKidney® — NOT_YET_RECRUITING · NA
• Preserving Kidney Function in Children With Chronic Kidney Disease — COMPLETED
• Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease — OTHER · NA
• The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques — OTHER
• Empowering Veterans to Communicate With Healthcare Providers — TERMINATED · NA
• Desidustat in the Treatment of Anemia in CKD — COMPLETED · PHASE3
• The Association Between the Duration of Acute Kidney Injury and New-onset Chronic Kidney Disease After Cardiac or Thoracic Aortic Surgery — COMPLETED
• Study to Assess PK, Safety and Tolerability in Patients With DM and CKD — COMPLETED · PHASE1
• Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control — COMPLETED · PHASE3
• Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients — OTHER · NA
• Short-term Effect of a New Nordic Renal Diet on Phosphorus Homeostasis in CKD Stage 3-4 — COMPLETED · NA
• Longitudinal change and cardiovascular (CV) impact of blood pressure adjusted pulse wave velocity in patients with advanced chronic kidney disease — NOT_YET_RECRUITING
• Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients — OTHER
• Effect of chronic kidney disease on leukocyte function — NOT_YET_RECRUITING
• Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol — COMPLETED · PHASE4
• Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients — OTHER · PHASE3

Refine this search